Ahmed Zaiem

Ahmed Zaiem

Auto-generated profile, based on publicly available information

Ahmed Zaiem

National Centre of Pharmacovigilance, 1006 Tunis, Tunisia; Tunis El Manar University, Medicine Faculty, Research Unit UR17ES12, La Rabta, 1007, Tunis, Tunisia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Therapies
Verified
Journal Article
Closed access
FZFatma Zgolli
Fatma Zgolli
OCOns Charfi
Ons Charfi
GLGhozlane Lakhoua
Ghozlane Lakhoua
SASihem El Aidli
Sihem El Aidli
IAImen Aouinti
Imen Aouinti
AZAhmed Zaiem
Ahmed Zaiem

12 July 2022 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
AZAhmed Zaiem
Ahmed Zaiem
SHSyrine Ben Hammamia
Syrine Ben Hammamia
IAImen Aouinti
Imen Aouinti
OCOns Charfi
Ons Charfi
WLWalid Ladhari
Walid Ladhari
GLGhozlane Lakhoua
Ghozlane Lakhoua
INTRODUCTION: Chemotherapy drugs can be responsible of several side effects such as hand–foot syndrome (HFS). This syndrome is also called “palmar-plantar erythrodysesthesia” and “acral erythema.” Without proper management, it can deteriorate the quality of life of a patient, leading to temporary or definitive stop of chemotherapy. AIM OF THIS STUDY: To identify the epidemiological and clinical characteristics of patients, the risk factors for occurrence and worsening of this syndrome, and the drugs most likely to be responsible of HFS. METHODS: Our study was retrospective, including 42 patients with HFS secondary to a chemotherapy drug. These cases were notified to the National Center of Pharmacovigilance over 7 years. The severity of HFS has been classified according to the NCI-CTCAE v4.0 classification. RESULTS: Our population was composed of 40 women and 2 men. The mean age was 51 years. Docetaxel was the main drug associated with this adverse effect. Hands were involved in all cases and were sometimes associated with other skin surfaces apart from feet. Erythema of the hands and/or feet was present in all patients; it was associated with edema in more than half of the cases. The distribution of different grades according to the NCI-CTCAE classification among the patients was almost equal: 28% Grade 1, 36% Grade 2, and 36% Grade 3. HFS occurred mainly after the first course of chemotherapy with a mean period of 3–4 days. The regression of HFS occurred more rapidly for Grade 1 and Grade 2 compared with Grade 3, especially when assisted by symptomatic treatment. The recurrence rate of HFS for those patients with decreased doses, spacing of cures, and/or symptomatic and prophylaxis treatment was 25%. CONCLUSION: An early detection of HFS, associated with preventive measures, enables patients to continue the chemotherapy.

1 November 2015 in Therapies
Verified
Journal Article
Closed access
PDF file
OCOns Charfi
Ons Charfi
GLGhozlane Lakhoua
Ghozlane Lakhoua
RSRim Sahnoun
Rim Sahnoun
TBTalel Badri
Talel Badri
RDRiadh Daghfous
Riadh Daghfous
AZAhmed Zaïem
Ahmed Zaïem

1 March 2016 in La Presse Médicale
Verified
Journal Article
Closed access
GLGhozlane Lakhoua
Ghozlane Lakhoua
IAimen aouinti
imen aouinti
RSRim Sahnoun
Rim Sahnoun
SKSarrah Kastalli
Sarrah Kastalli
RDRiadh Daghfous
Riadh Daghfous
AZAhmed Zaïem
Ahmed Zaïem

1 January 2015 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
AZAhmed Zaïem
Ahmed Zaïem
OCOns Charfi
Ons Charfi
TBTalel Badri
Talel Badri
SESihem Elaidli
Sihem Elaidli

6 July 2010 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
SKSarrah Kastalli
Sarrah Kastalli
SASihem El Aïdli
Sihem El Aïdli
AZAhmed Zaïem
Ahmed Zaïem
HAHatem Ben Abdallah
Hatem Ben Abdallah
RDRiadh Daghfous
Riadh Daghfous